Fruit Jelly Cups Recalled For Choking Risks

Rong Shing Trading NY Inc. is recalling certain Xi Zhi Liang Konjac powder Fruit Jelly Cups, citing choking risks to children, the U.S. Food and Drug Administration said in a statement.

The recall was initiated as small jelly cups containing konjac powder have been implicated in choking deaths of children earlier. At present, small konjac powder jelly cups are under FDA import alert 35-15 and are not permitted for entry into the United States.

Meanwhile, Brooklyn, New York-based Rong Shing has not received any choking incidents related to its products.

The latest recall involves 21.1oz (600g) of Xi Zhi Liang Fruit Jelly Cups with UPC code of “6902934982138” and Best Before date of December 30, 2020.

The affected item comes in pink, yellow, and blue plastic backpacks. Inside each pack, there are numerous individual plastic jelly cups, and a toy car in a pouch on the front of the plastic backpack.

The recalled jelly cups were distributed in retail food stores across the United States.

Consumers are asked to return the products for a full refund.

In similar recalls, Bonnsu LLC, doing business as Miniware, last week recalled about 32,200 units of Miniware Teething Spoons citing chocking risks to infants.

For the same concerns, Manhattan Toy Co. LLC in early April called back about 4,000 units of Musical Lili Llama toys and Chicago, Illinois-based Contigo USA in February called back around 5.7 million of already recalled kids Water Bottles, due to issues with the replaced lids.

Indian exports fall by over 36% in May

NEW DELHI (Reuters) – India’s merchandise exports shrank by more than a third in May from a year ago, dragged down by a fall in global demand and shipments due to the outbreak of coronavirus, trade ministry data showed on Monday.

Merchandise exports INEXP=ECI were down by 36.47% to $19.05 billion in May, while imports INIMP=ECI were down 51.05% to $22.20 billion, the data showed.

Storm Cristobal Weakens To Tropical Depression

Tropical Storm Cristobal weakened to a tropical depression Monday morning after making landfall in Southeast Louisiana on Sunday evening, producing dangerous flooding.

The third named storm of the 2020 Atlantic hurricane season, Cristobal made landfall after 5 p.m., and is forecast to bring heavy rain and tropical storm-force wind gusts into Mississippi and Alabama.

The National Hurricane Center (NHC) said that Cristobal is forecast to produce rainfall amounts of 5 to 10 inches from the central and eastern Gulf Coast into the lower Mississippi Valley, with winds having a force of near 35 mph.

An NHC advisory issued at 10 AM CDT said the center of Cristobal is expected to move through northeastern Louisiana today, through Arkansas and eastern Missouri
tonight and Tuesday, and reach Wisconsin and the western Great Lakes by Wednesday.

Some weakening is forecast through Tuesday. However, Cristobal is expected to gain strength as it becomes an extratropical low Tuesday night and Wednesday, it added.

The weather agency warned that isolated tornadoes are possible today and tonight across Mississippi, Alabama, southeastern Louisiana, eastern Arkansas, western Tennessee, and southeastern Missouri.

Workers Can’t Be Fired for LGBT Status, U.S. Supreme Court Says

A divided U.S. Supreme Court ruled that federal law protects gay and transgender workers from job discrimination in a pair of decisions that give millions of LGBT people new civil rights.

Conservative Justice Neil Gorsuch and Chief Justice John Roberts joined the court’s four liberals in a 6-3 majority, interpreting the longstanding federal ban on sex discrimination in the workplace to cover bias on the basis of sexual orientation and gender identity.

The decisions could have a broad practical impact. More than half the U.S. states don’t cover sexual orientation and gender identity through their own anti-discrimination laws. More than half the nation’s 8 million LGBT workers live in those states, according to the UCLA School of Law’s Williams Institute.

The victory for LGBT rights comes even after the Supreme Court shifted to the right with two appointments by President Donald Trump.

The cases tackled a central irony in the fight over LGBT rights. Even though the Supreme Court legalized same-sex marriage nationwide in 2015, LGBT people still could have been fired from their jobs in much of the country.

Stock Alert: Shopify Ticking Higher

Shares of cloud-based multi-channel commerce platform provider Shopify Inc. (SHOP) are advancing more than 7% Monday morning on the news of Walmart partnering with it.

Walmart Inc. has partnered with Shopify to expand its online market place by adding small businesses and to take advantage of the current pandemic situation driven surge in the sales.

The e-commerce giant plans to add 1,200 Shopify sellers this year.

Shopify stock is currently trading at $797.73. It has traded in the range of $281.69- $844 in the past 52 weeks.

Stock Alert: Humanigen Gains 30% On Positive News Related To Its Drug Candidate Lenzilumab

Shares of Humanigen, Inc. (HGEN) are climbing more than 30% Monday morning after the clinical-stage biopharmaceutical company announced that its drug candidate lenzilumab showed rapid recovery and discharge in critical Covid-19 patients. The stock hit a new high of $6.30, currently trading at $5.40.

Humanigen announced positive data from the study of Lenzilumab, the company’s proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, in 12 Covid-19 patients.

Patients showed rapid clinical improvement with a median time to recovery of five days, median time to discharge of five days, and 100% survival to the data cut-off date. Patients also demonstrated rapid improvement in oxygenation, temperature, inflammatory cytokines, and key hematological parameters consistent with improved clinical outcomes.

Dr. Cameron Durrant, chief executive officer of Humanigen, stated, “It is extremely encouraging to see this initial group of high-risk patients with severe and critical COVID-19 pneumonia show clinical improvement on lenzilumab..”